Table 5.
Clinical signs and symptoms for development of the new stroke scale
| Variables | Score | β | OR (95 % CI) | P value |
|---|---|---|---|---|
| Vertigo | −1 | −1.09 | 0.34 (0.15–0.74) | 0.007* |
| GCS ≤ 8 | 2 | 1.74 | 5.70 (1.26–25.80) | 0.024* |
| Asymmetric facial weakness | 1 | 0.89 | 2.44 (0.97–6.11) | 0.057 |
| Asymmetric arm weakness | 1 | 1.22 | 3.39 (1.04–11.08) | 0.043* |
| Asymmetric leg weakness | 1 | 1.02 | 2.77 (0.88–8.70) | 0.081 |
| Speech disturbance | 0.5 | 0.26 | 1.29 (0.58–2.84) | 0.524 |
| Visual field defect | 1 | 1.37 | 3.93 (0.48–32.30) | 0.202 |
| SBP ≥ 145 mmHg | 1 | 0.94 | 2.55 (1.25–5.24) | 0.011* |
| DBP ≥ 95 mmHg | 1 | 0.83 | 2.29 (0.87–6.03) | 0.093 |
*P < 0.05
Stroke is likely if total scores are >1.5